Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garvey

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 21, 2014
Design and optimization of highly-selective fungal CYP51 inhibitorsWilliam J Hoekstra, Edward P Garvey, William R Moore, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasisE P Garvey, W J Hoekstra, R J Schotzinger, et al.
BMC Endocrine Disorders|July 15, 2022
A systematic review of patient-reported outcome measures in paediatric endocrinologyRichard G McGee, Edward Y B Zhang, Jennifer J G Tan, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2017
Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in DogsLisa F Shubitz, Michael E Roy, Hien T Trinh, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2017
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizusNathan P Wiederhold, Hoja P Patterson, Bich Hue Tran, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89M B Faletto, W H Miller, E P Garvey, et al.
The Journal of Biological Chemistry|April 8, 1994
Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cellsR Arrebola, A Olmo, P Reche, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2018
Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analoguesBinto Simon, Claire Walmsley, Victoria J Jackson, et al.
Medical Mycology|June 2, 2020
The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosisE P Garvey, A D Sharp, P A Warn, et al.
Biochemistry|January 31, 2009
Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutantEdward P Garvey, Benjamin Schwartz, Margaret J Gartland, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|June 21, 2014
Design and optimization of highly-selective fungal CYP51 inhibitorsWilliam J Hoekstra, Edward P Garvey, William R Moore, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasisE P Garvey, W J Hoekstra, R J Schotzinger, et al.
BMC Endocrine Disorders|July 15, 2022
A systematic review of patient-reported outcome measures in paediatric endocrinologyRichard G McGee, Edward Y B Zhang, Jennifer J G Tan, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2017
Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in DogsLisa F Shubitz, Michael E Roy, Hien T Trinh, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2017
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizusNathan P Wiederhold, Hoja P Patterson, Bich Hue Tran, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89M B Faletto, W H Miller, E P Garvey, et al.
The Journal of Biological Chemistry|April 8, 1994
Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cellsR Arrebola, A Olmo, P Reche, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2018
Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analoguesBinto Simon, Claire Walmsley, Victoria J Jackson, et al.
Medical Mycology|June 2, 2020
The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosisE P Garvey, A D Sharp, P A Warn, et al.
Biochemistry|January 31, 2009
Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutantEdward P Garvey, Benjamin Schwartz, Margaret J Gartland, et al.
Pageof 13